Refine your search
118 trials found
Recruiting
(118)
Not yet recruiting
Recruiting
NCT06215118
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Multiple Myeloma
Male or Female
18+ years
34study location(s)
Recruiting
NCT05317416
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Multiple Myeloma
Male or Female
18+ years
221study location(s)
Recruiting
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Male or Female
18+ years
211study location(s)
Recruiting
NCT05675449
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Multiple Myeloma
Male or Female
18+ years
32study location(s)
Recruiting
NCT06137742
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Male or Female
18 - 65 years
27study location(s)
Recruiting
NCT05070845
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia
Male or Female
18 - 70 years
28study location(s)
Recruiting
NCT06551324
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Males
18+ years
202study location(s)
Recruiting
NCT05895786
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Male or Female
18+ years
127study location(s)
Recruiting
NCT04624230
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
Ulcerative Colitis
Male or Female
2 - 17 years
77study location(s)
Recruiting
NCT05879718
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.
Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous
Male or Female
18 - 75 years
36study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
(118)
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.